Literature DB >> 19821093

Fabrication of a novel hybrid scaffold for tissue engineered heart valve.

Hao Hong1, Nianguo Dong, Jiawei Shi, Si Chen, Chao Guo, Ping Hu, Hongxu Qi.   

Abstract

The aim of this study was to fabricate biomatrix/polymer hybrid scaffolds using an electrospinning technique. Then tissue engineered heart valves were engineered by seeding mesenchymal stromal cells (MSCs) onto the scaffolds. The effects of the hybrid scaffolds on the proliferation of seed cells, formation of extracellular matrix and mechanical properties of tissue engineered heart valves were investigated. MSCs were obtained from rats. Porcine aortic heart valves were decellularized, coated with poly(3-hydroxybutyrate-co-4-hydroxybutyrate) using an electrospinning technique, and reseeded and cultured over a time period of 14 days. In control group, the decellularized valve scaffolds were reseeded and cultured over an equivalent time period. Specimens of each group were examined histologically (hematoxylin-eosin [HE] staining, immunohistostaining, and scanning electron microscopy), biochemically (DNA and 4-hydroxyproline) and mechanically. The results showed that recellularization was comparable to the specimens of hybrid scaffolds and controls. The specimens of hybrid scaffolds and controls revealed comparable amounts of cell mass and 4-hydroxyproline (P>0.05). However, the specimens of hybrid scaffolds showed a significant increase in mechanical strength, compared to the controls (P<0.05). This study demonstrated the superiority of the hybrid scaffolds to increase the mechanical strength of tissue engineered heart valves. And compared to the decellularized valve scaffolds, the hybrid scaffolds showed similar effects on the proliferation of MSCs and formation of extracellular matrix. It was believed that the hybrid scaffolds could be used for the construction of tissue engineered heart valves.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19821093     DOI: 10.1007/s11596-009-0513-6

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  14 in total

1.  Effect of gamma-hydroxybutyric acid on human platelet aggregation in vitro.

Authors:  F Franconi; M Miceli; L Alberti; G Boatto; R Coinu; M G De Montis; A Tagliamonte
Journal:  Thromb Res       Date:  2001-05-01       Impact factor: 3.944

2.  Complete dynamic repopulation of decellularized heart valves by application of defined physical signals-an in vitro study.

Authors:  K Schenke-Layland; F Opitz; M Gross; C Döring; K J Halbhuber; F Schirrmeister; Th Wahlers; U A Stock
Journal:  Cardiovasc Res       Date:  2003-12-01       Impact factor: 10.787

3.  Controlled fabrication of a biological vascular substitute.

Authors:  Joel Stitzel; Jie Liu; Sang Jin Lee; Makoto Komura; Joel Berry; Shay Soker; Grace Lim; Mark Van Dyke; Richard Czerw; James J Yoo; Anthony Atala
Journal:  Biomaterials       Date:  2005-08-29       Impact factor: 12.479

4.  Performance of decellularized xenogeneic tissue in heart valve replacement.

Authors:  Ulrich A Stock; Katja Schenke-Layland
Journal:  Biomaterials       Date:  2006-01       Impact factor: 12.479

5.  Biological scaffolds for heart valve tissue engineering.

Authors:  Artur Lichtenberg; Serghei Cebotari; Igor Tudorache; Andres Hilfiker; Axel Haverich
Journal:  Methods Mol Med       Date:  2007

Review 6.  Tissue engineering of heart valves using decellularized xenogeneic or polymeric starter matrices.

Authors:  Dörthe Schmidt; Ulrich A Stock; Simon P Hoerstrup
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-08-29       Impact factor: 6.237

Review 7.  The use of acellular matrices for the tissue engineering of cardiac valves.

Authors:  R L Knight; H E Wilcox; S A Korossis; J Fisher; E Ingham
Journal:  Proc Inst Mech Eng H       Date:  2008-01       Impact factor: 1.617

8.  Living autologous heart valves engineered from human prenatally harvested progenitors.

Authors:  Dörthe Schmidt; Anita Mol; Christian Breymann; Josef Achermann; Bernhard Odermatt; Matthias Gössi; Stefan Neuenschwander; René Prêtre; Michele Genoni; Gregor Zund; Simon P Hoerstrup
Journal:  Circulation       Date:  2006-07-04       Impact factor: 29.690

9.  Engineering of vascular grafts with genetically modified bone marrow mesenchymal stem cells on poly (propylene carbonate) graft.

Authors:  Jun Zhang; Hongxu Qi; Hongjun Wang; Ping Hu; Lailiang Ou; Shuhua Guo; Jing Li; Yongzhe Che; Yaoting Yu; Deling Kong
Journal:  Artif Organs       Date:  2006-12       Impact factor: 3.094

10.  A new source for cardiovascular tissue engineering: human bone marrow stromal cells.

Authors:  Alexander Kadner; Simon P Hoerstrup; Gregor Zund; Karim Eid; Christine Maurus; Serguei Melnitchouk; Jurg Grunenfelder; Marko I Turina
Journal:  Eur J Cardiothorac Surg       Date:  2002-06       Impact factor: 4.191

View more
  2 in total

Review 1.  Tissue-engineered heart valve: future of cardiac surgery.

Authors:  Radoslaw A Rippel; Hossein Ghanbari; Alexander M Seifalian
Journal:  World J Surg       Date:  2012-07       Impact factor: 3.352

Review 2.  Recellularization of decellularized heart valves: Progress toward the tissue-engineered heart valve.

Authors:  Mitchell C VeDepo; Michael S Detamore; Richard A Hopkins; Gabriel L Converse
Journal:  J Tissue Eng       Date:  2017-08-25       Impact factor: 7.813

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.